CLT-LANA Detailed Content Outline

The following are detailed outlines of the content and sub-content areas covered in the examination, along with their respective weightings showing what percentage of the examination questions are covered by each main content area. The examination consists of 130 multiple choice questions with four options, only one of which is correct. Twenty of these questions are included for research purposes only. The research questions are not identified; therefore, candidates must answer all questions to their best ability.

DOMAIN 1. Anatomy and Physiology 25%

  1. Distinguish among anatomical structures of the human body
    1. Venous and arterial circulatory systems
    2. Lymphatic system
      1. Embryology
      2. Lymphangiogenesis
      3. Prelymphatic channels
      4. Lymphatic vessels
      5. Lymph nodes
      6. Lympho-venous anastomoses
      7. Watersheds and collateral anastomoses
      8. Superficial drainage pathways
      9. Deep drainage pathways
    3. Integumentary system
    4. Interstitium
  2. Demonstrate understanding of physiological functions
    1. Circulatory and lymphatic systems
    2. Microcirculation
      1. Starlings and Revised Starling’s hypotheses and equilibrium
      2. Safety factors that prevent edema
    3. Musculoskeletal system
    4. Interstitium
      1. Adipose tissue
      2. Inflammation

DOMAIN 2. Lymphedema, Vascular, and Related Disorders (e.g., primary and secondary lymphedema, fat disorders, arteriovenous disease) 30%

  1. Differentiate etiologies
  2. Identify pathology and pathophysiology
  3. Distinguish signs and symptoms

DOMAIN 3. Patient Evaluation and Treatment Planning 15%

  1. Obtain a comprehensive patient history
  2. Determine functional status
  3. Conduct a comprehensive patient examination including:
    1. Vital signs and peripheral pulses
    2. Cognition and affect
    3. Neuromusculoskeletal assessment
    4. Integumentary assessment
    5. Measurements
    6. Appearance, clinical signs, and staging
  4. Identify purpose and procedural techniques of diagnostic tests
  5. Review diagnostic and lab tests results
  6. Identify early interventions for at-risk populations
  7. Formulate individualized treatment plan and goals

DOMAIN 4. Management of Lymphedema and Related Disorders 30%

  1. Integrate principles of complete decongestive therapy (CDT) in clinical settings
    1. Manual lymphatic drainage (MLD)
    2. Compression bandaging and garments
    3. Decongestive and functional exercises
    4. Skin and wound care
  2. Integrate core principles of adjunct clinical treatments and modalities
    1. Fibrosis, soft tissue, and scar management
    2. Elastic/kinesiology taping
    3. Intermittent pneumatic compression (IPC)
    4. Emerging therapies
  3. Formulate patient education and transition to self-management
    1. Activities of Daily Living (ADL) modifications
    2. Compression bandaging and garments
    3. Home program and therapeutic and recreational exercise
    4. Lymphatic drainage
    5. Weight management and nutrition
    6. Precautions and risk reduction practice
    7. Skin care
    8. Signs and symptoms of infection
    9. Nonelastic containment systems
    10. Intermittent pneumatic compression (IPC)
  4. Identify adaptations to treatment for special populations and needs
    1. Pediatrics
    2. Palliative care
    3. Bariatric (BMI > 40)
  5. Recognize cognitive, physical, psychological, and socioeconomic factors that affect quality of life and treatment
  6. Analyze potential complications associated with lymphedema and comorbid conditions
    1. Medical conditions associated with lymphedema
    2. Medical conditions that are absolute contraindications to treatment
    3. Medical conditions that are relative contraindications to treatment
    4. Medical conditions that can affect lymphedema treatment outcomes
  7. Identify surgical interventions to manage lymphedema and related disorders
    1. Surgical treatments
    2. Pre-operative management
    3. Post-operative care
  8. Identify the implications of pharmaceutical and/or supplemental treatments
  9. Recognize the impact of cancer and cancer treatment on lymphedema management